Biomarkers of operational tolerance in solid organ transplantation

Bibliography

• Fishman JA. Infection in solid-organ transplant recipients. N Engl J Med 2007;357(25):2601-14
   PubMed Web of Science ®Google Scholar
• Kasiske BL, Snyder JJ, Gilbertson DT, Wang C. Cancer after kidney transplantation in the United States. Am J Transplant 2004;4(6):905-13
   PubMed Web of Science ®Google Scholar
• Ojo AO, Held PJ, Port FK, Chronic renal failure after transplantation of a nonrenal organ. N Engl J Med 2003;349(10):931-40
   PubMed Web of Science ®Google Scholar
• Bodziak KA, Hricik DE. New-onset diabetes mellitus after solid organ transplantation. Transpl Int 2009;22(5):519-30
   PubMed Web of Science ®Google Scholar
• Kingsley CI, Nadig SN, Wood KJ. Transplantation tolerance: lessons from experimental rodent models. Transpl Int 2007;20(10):828-41
   PubMed Web of Science ®Google Scholar
• Auchincloss H Jr. In search of the elusive Holy Grail: the mechanisms and prospects for achieving clinical transplantation tolerance. Am J Transplant 2001;1(1):6-12
   PubMed Web of Science ®Google Scholar
• Biomarkers Definitions Working Group. Biomarkers and surrogate endpoints: preferred definitions and conceptual framework. Clin Pharmacol Ther 2001;69(3):89-95
   PubMed Web of Science ®Google Scholar
• Solez K, Colvin RB, Racusen LC, Banff 07 classification of renal allograft pathology: updates and future directions. Am J Transplant 2008;8(4):753-60
   PubMed Web of Science ®Google Scholar
• Goldman M, Wood K. Transplantation research: will we ever reach the holy grail? Transplantation 2009;87(9 Suppl):S99-100
   PubMed Web of Science ®Google Scholar
• Martinez-Llordella M, Lozano JJ, Puig-Pey I, Using transcriptional profiling to develop a diagnostic test of operational tolerance in liver transplant recipients. J Clin Invest 2008;118(8):2845-57
   PubMed Web of Science ®Google Scholar
• Brouard S, Le Bars A, Dufay A, Identification of a gene expression profile associated with operational tolerance among a selected group of stable kidney transplant patients. Transpl Int 2011;24(6):536-47
   PubMed Web of Science ®Google Scholar
• Orlando G, Soker S, Wood K. Operational tolerance after liver transplantation. J Hepatol 2009;50(6):1247-57
   PubMed Web of Science ®Google Scholar
• Opelz G, Dohler B. Effect on kidney graft survival of reducing or discontinuing maintenance immunosuppression after the first year posttransplant. Transplantation 2008;86(3):371-6
   PubMed Web of Science ®Google Scholar
• Starzl TE. The ‘privileged’ liver and hepatic tolerogenicity. Liver transpl 2001;7(10):918-20
   PubMed Web of Science ®Google Scholar
• Ramos HC, Reyes J, Abu-Elmagd K, Weaning of immunosuppression in long-term liver transplant recipients. Transplantation 1995;59(2):212-17
   PubMed Web of Science ®Google Scholar
• Mazariegos GV, Reyes J, Marino IR, Weaning of immunosuppression in liver transplant recipients. Transplantation 1997;63(2):243-9
   PubMed Web of Science ®Google Scholar
• Takatsuki M, Uemoto S, Inomata Y, Weaning of immunosuppression in living donor liver transplant recipients. Transplantation 2001;72(3):449-54
   PubMed Web of Science ®Google Scholar
• Tzakis AG, Reyes J, Zeevi A, Early tolerance in pediatric liver allograft recipients. J Pediatr Surg 1994;29(6):754-6
   PubMed Web of Science ®Google Scholar
• Li Y, Koshiba T, Yoshizawa A, Analyses of peripheral blood mononuclear cells in operational tolerance after pediatric living donor liver transplantation. Am J Transplant 2004;4(12):2118-25
   PubMed Web of Science ®Google Scholar
• Martinez-Llordella M, Puig-Pey I, Orlando G, Multiparameter immune profiling of operational tolerance in liver transplantation. Am J Transplant 2007;7(2):309-19
   PubMed Web of Science ®Google Scholar
• Li L, Wozniak LJ, Rodder S, A common peripheral blood gene set for diagnosis of operational tolerance in pediatric and adult liver transplantation. Am J Transplant 2012; doi: 10.1111/j.1600-6143.2011.03928.x
   Web of Science ®Google Scholar
• Koshiba T, Li Y, Takemura M, Clinical, immunological, and pathological aspects of operational tolerance after pediatric living-donor liver transplantation. Transpl Immunol 2007;17(2):94-7
   PubMed Web of Science ®Google Scholar
• Puig-Pey I, Bohne F, Benitez C, Characterization of gammadelta T cell subsets in organ transplantation. Transpl Int 2010;23(10):1045-55
   PubMed Web of Science ®Google Scholar
• Mazariegos GV, Sindhi R, Thomson AW, Marcos A. Clinical tolerance following liver transplantation: long term results and future prospects. Transpl Immunol 2007;17(2):114-19
   PubMed Web of Science ®Google Scholar
• Pons JA, Revilla-Nuin B, Baroja-Mazo A, FoxP3 in peripheral blood is associated with operational tolerance in liver transplant patients during immunosuppression withdrawal. Transplantation 2008;86(10):1370-8
   PubMed Web of Science ®Google Scholar
• Tokita D, Mazariegos GV, Zahorchak AF, High PD-L1/CD86 ratio on plasmacytoid dendritic cells correlates with elevated T-regulatory cells in liver transplant tolerance. Transplantation 2008;85(3):369-77
   PubMed Web of Science ®Google Scholar
• Wood KJ, Sakaguchi S. Regulatory T cells in transplantation tolerance. Nat Rev Immunol 2003;3(3):199-210
   PubMed Web of Science ®Google Scholar
• Nadig SN, Wieckiewicz J, Wu DC, In vivo prevention of transplant arteriosclerosis by ex vivo-expanded human regulatory T cells. Nat Med 2010;16(7):809-13
   PubMed Web of Science ®Google Scholar
• Castellaneta A, Mazariegos GV, Nayyar N, HLA-G level on monocytoid dendritic cells correlates with regulatory T-cell Foxp3 expression in liver transplant tolerance. Transplantation 2011;91(10):1132-40
   PubMed Web of Science ®Google Scholar
• Li Y, Zhao X, Cheng D, The presence of Foxp3 expressing T cells within grafts of tolerant human liver transplant recipients. Transplantation 2008;86(12):1837-43
   PubMed Web of Science ®Google Scholar
• Kovats S, Main EK, Librach C, A class I antigen, HLA-G, expressed in human trophoblasts. Science 1990;248(4952):220-3
   PubMed Web of Science ®Google Scholar
• Deschaseaux F, Delgado D, Pistoia V, HLA-G in organ transplantation: towards clinical applications. Cell Mol Life Sci 2011;68(3):397-404
   PubMed Web of Science ®Google Scholar
• Zarkhin V, Talisetti A, Li L, Expression of soluble HLA-G identifies favorable outcomes in liver transplant recipients. Transplantation 2010;90(9):1000-5
   PubMed Web of Science ®Google Scholar
• Mazariegos GV, Zahorchak AF, Reyes J, Dendritic cell subset ratio in peripheral blood correlates with successful withdrawal of immunosuppression in liver transplant patients. Am J Transplant 2003;3(6):689-96
   PubMed Web of Science ®Google Scholar
• Mazariegos GV, Zahorchak AF, Reyes J, Dendritic cell subset ratio in tolerant, weaning and non-tolerant liver recipients is not affected by extent of immunosuppression. Am J Transplant 2005;5(2):314-22
   PubMed Web of Science ®Google Scholar
• Mueller DL. Mechanisms maintaining peripheral tolerance. Nat immunol 2010;11(1):21-7
   PubMed Web of Science ®Google Scholar
• Sagoo P, Perucha E, Sawitzki B, Development of a cross-platform biomarker signature to detect renal transplant tolerance in humans. J Clin Invest 2010;120(6):1848-61
   PubMed Web of Science ®Google Scholar
• Newell KA, Asare A, Kirk AD, Identification of a B cell signature associated with renal transplant tolerance in humans. J Clin Invest 2010;120(6):1836-47
   PubMed Web of Science ®Google Scholar
• Lozano JJ, Pallier A, Martinez-Llordella M, Comparison of transcriptional and blood cell-phenotypic markers between operationally tolerant liver and kidney recipients. Am J Transplant 2011;11(9):1916-26
   PubMed Web of Science ®Google Scholar
• Louis S, Braudeau C, Giral M, Contrasting CD25hiCD4+T cells/FOXP3 patterns in chronic rejection and operational drug-free tolerance. Transplantation 2006;81(3):398-407
   PubMed Web of Science ®Google Scholar
• Pallier A, Hillion S, Danger R, Patients with drug-free long-term graft function display increased numbers of peripheral B cells with a memory and inhibitory phenotype. Kidney Int 2010;78(5):503-13
   PubMed Web of Science ®Google Scholar
• Liu C, Noorchashm H, Sutter JA, B lymphocyte-directed immunotherapy promotes long-term islet allograft survival in nonhuman primates. Nat Med 2007;13(11):1295-8
   PubMed Web of Science ®Google Scholar
• Zarkhin V, Lovelace PA, Li L, Phenotypic evaluation of B-cell subsets after rituximab for treatment of acute renal allograft rejection in pediatric recipients. Transplantation 2011;91(9):1010-18
   PubMed Web of Science ®Google Scholar
• Blair PA, Norena LY, Flores-Borja F, CD19(+)CD24(hi)CD38(hi) B cells exhibit regulatory capacity in healthy individuals but are functionally impaired in systemic lupus erythematosus patients. Immunity 2010;32(1):129-40
   PubMed Web of Science ®Google Scholar
• Chong AS, Sciammas R. Matchmaking the B-cell Signature of Tolerance to Regulatory B cells. Am J Transplant 2011;11(12):2555-60
   PubMed Web of Science ®Google Scholar
• Matsushita T, Yanaba K, Bouaziz JD, Regulatory B cells inhibit EAE initiation in mice while other B cells promote disease progression. J Clin Invest 2008;118(10):3420-30
   PubMed Web of Science ®Google Scholar
• Iwata Y, Matsushita T, Horikawa M, Characterization of a rare IL-10-competent B-cell subset in humans that parallels mouse regulatory B10 cells. Blood 2011;117(2):530-41
   PubMed Web of Science ®Google Scholar
• Le Texier L, Thebault P, Lavault A, Long-term allograft tolerance is characterized by the accumulation of B cells exhibiting an inhibited profile. Am J Transplant 2011;11(3):429-38
   PubMed Web of Science ®Google Scholar
• Roussey-Kesler G, Giral M, Moreau A, Clinical operational tolerance after kidney transplantation. Am J Transplant 2006;6(4):736-46
   PubMed Web of Science ®Google Scholar
• Brouard S, Dupont A, Giral M, Operationally tolerant and minimally immunosuppressed kidney recipients display strongly altered blood T-cell clonal regulation. Am J Transplant 2005;5(2):330-40
   PubMed Web of Science ®Google Scholar
• Baeten D, Louis S, Braud C, Phenotypically and functionally distinct CD8+ lymphocyte populations in long-term drug-free tolerance and chronic rejection in human kidney graft recipients. J Am Soc Nephrol 2006;17(1):294-304
   PubMed Web of Science ®Google Scholar
• Brouard S, Mansfield E, Braud C, Identification of a peripheral blood transcriptional biomarker panel associated with operational renal allograft tolerance. Proc Natl Acad Sci USA 2007;104(39):15448-53
   PubMed Web of Science ®Google Scholar
• Sawitzki B, Bushell A, Steger U, Identification of gene markers for the prediction of allograft rejection or permanent acceptance. Am J Transplant 2007;7(5):1091-102
   PubMed Web of Science ®Google Scholar
• Long ET, Baker S, Oliveira V, Alpha-1,2-mannosidase and hence N-glycosylation are required for regulatory T cell migration and allograft tolerance in mice. PLoS One 2010;5(1):e8894
   PubMedGoogle Scholar
• Haynes LD, Jankowska-Gan E, Sheka A, Donor-specific indirect pathway analysis reveals a B-cell-independent signature which reflects outcomes in kidney transplant recipients. Am J Transplant 2012;12(3):640-8
   PubMed Web of Science ®Google Scholar
• Jones ND, Turvey SE, Van Maurik A, Differential susceptibility of heart, skin, and islet allografts to T cell-mediated rejection. J immunol 2001;166(4):2824-30
   PubMed Web of Science ®Google Scholar
• Lerut J, Sanchez-Fueyo A. An appraisal of tolerance in liver transplantation. Am J Transplant 2006;6(8):1774-80
   PubMed Web of Science ®Google Scholar
• Kawai T, Cosimi AB, Spitzer TR, HLA-mismatched renal transplantation without maintenance immunosuppression. N Engl J Med 2008;358(4):353-61
   PubMed Web of Science ®Google Scholar
• Scandling JD, Busque S, Shizuru JA, Induced immune tolerance for kidney transplantation. N Engl J Med 2011;365(14):1359-60
   PubMed Web of Science ®Google Scholar
• Neujahr D, Turka LA. Lymphocyte depletion as a barrier to immunological tolerance. Contrib Nephrol 2005;146:65-72
   PubMed Web of Science ®Google Scholar
• Shapiro R, Jordan ML, Basu A, Kidney transplantation under a tolerogenic regimen of recipient pretreatment and low-dose postoperative immunosuppression with subsequent weaning. Ann Surg 2003;238(4):520-5; discussion 5-7
   PubMed Web of Science ®Google Scholar
• Shapiro R, Basu A, Tan H, Kidney transplantation under minimal immunosuppression after pretransplant lymphoid depletion with thymoglobulin or campath. J Am Coll Surg 2005;200(4):505-15; quiz A59-61
   PubMed Web of Science ®Google Scholar
• D'Addio F, Yuan X, Habicht A, A novel clinically relevant approach to tip the balance toward regulation in stringent transplant model. Transplantation 2010;90(3):260-9
   PubMed Web of Science ®Google Scholar
• Calne R, Friend P, Moffatt S, Prope tolerance, perioperative campath 1H, and low-dose cyclosporin monotherapy in renal allograft recipients. Lancet 1998;351(9117):1701-2
   PubMed Web of Science ®Google Scholar
• Calne R, Watson CJ. Some observations on prope tolerance. Curr Opin Organ Transplant 2011;16(4):353-8
   PubMed Web of Science ®Google Scholar
• Noris M, Casiraghi F, Todeschini M, Regulatory T cells and T cell depletion: role of immunosuppressive drugs. J Am Soc Nephrol 2007;18(3):1007-18
   PubMed Web of Science ®Google Scholar
• Bloom DD, Chang Z, Fechner JH, CD4+ CD25+ FOXP3+ regulatory T cells increase de novo in kidney transplant patients after immunodepletion with campath-1H. Am J Transplant 2008;8(4):793-802
   PubMed Web of Science ®Google Scholar
• Pascual J, Bloom D, Torrealba J, Calcineurin inhibitor withdrawal after renal transplantation with alemtuzumab: clinical outcomes and effect on T-regulatory cells. Am J Transplant 2008;8(7):1529-36
   PubMed Web of Science ®Google Scholar
• Trzonkowski P, Zilvetti M, Chapman S, Homeostatic repopulation by CD28-CD8+ T cells in alemtuzumab-depleted kidney transplant recipients treated with reduced immunosuppression. Am J Transplant 2008;8(2):338-47
   PubMed Web of Science ®Google Scholar
• Heidt S, Hester J, Shankar S, B-Cell repopulation after alemtuzumab induction – transient increase in transitional B cells and long-term dominance of naïve B cells. Am J Transplant 2012; doi: 10.1111/j.1600-6143.2012.04012.x
   Google Scholar
• Pearl JP, Parris J, Hale DA, Immunocompetent T-cells with a memory-like phenotype are the dominant cell type following antibody-mediated T-cell depletion. Am J Transplant 2005;5(3):465-74
   PubMed Web of Science ®Google Scholar
• Trzonkowski P, Zilvetti M, Friend P, Wood KJ. Recipient memory-like lymphocytes remain unresponsive to graft antigens after CAMPATH-1H induction with reduced maintenance immunosuppression. Transplantation 2006;82(10):1342-51
   PubMed Web of Science ®Google Scholar
• Knechtle SJ, Pascual J, Bloom DD, Early and limited use of tacrolimus to avoid rejection in an alemtuzumab and sirolimus regimen for kidney transplantation: clinical results and immune monitoring. Am J Transplant 2009;9(5):1087-98
   PubMed Web of Science ®Google Scholar
• Perry DK, Burns JM, Pollinger HS, Proteasome inhibition causes apoptosis of normal human plasma cells preventing alloantibody production. Am J Transplant 2009;9(1):201-9
   PubMed Web of Science ®Google Scholar
• Heidt S, Roelen DL, Vergunst M, Bortezomib affects the function of human B cells: possible implications for desensitization protocols. Clin Transpl 2009;387-92
   PubMedGoogle Scholar
• Trivedi HL, Terasaki PI, Feroz A, Clonal deletion with bortezomib followed by low or no maintenance immunosuppression in renal allograft recipients. Transplantation 2010;90(2):221-2
   PubMed Web of Science ®Google Scholar
• Terasaki PI. The beneficial transfusion effect on kidney graft survival attributed to clonal deletion. Transplantation 1984;37(2):119-25
   PubMed Web of Science ®Google Scholar
• Dankers MK, Witvliet MD, Roelen DL, The number of amino acid triplet differences between patient and donor is predictive for the antibody reactivity against mismatched human leukocyte antigens. Transplantation 2004;77(8):1236-9
   PubMed Web of Science ®Google Scholar
• Adams AB, Williams MA, Jones TR, Heterologous immunity provides a potent barrier to transplantation tolerance. J Clin Invest 2003;111(12):1887-95
   PubMed Web of Science ®Google Scholar
• Mauri C, Bosma A. Immune regulatory function of B cells. Annu Rev Immunol 2012;30:221-41
   PubMed Web of Science ®Google Scholar
• Ballet C, Roussey-Kesler G, Aubin JT, Humoral and cellular responses to influenza vaccination in human recipients naturally tolerant to a kidney allograft. Am J Transplant 2006;6(11):2796-801
   PubMed Web of Science ®Google Scholar
• Welsh RM, Markees TG, Woda BA, Virus-induced abrogation of transplantation tolerance induced by donor-specific transfusion and anti-CD154 antibody. J Virol 2000;74(5):2210-18
   PubMed Web of Science ®Google Scholar
• Issa F, Hester J, Goto R, Ex vivo-expanded human regulatory T cells prevent the rejection of skin allografts in a humanized mouse model. Transplantation 2010;90(12):1321-7
   PubMed Web of Science ®Google Scholar
• Wood KJ, Goto R. Mechanisms of rejection: current perspectives. Transplantation 2012;93(1):1-10
   PubMed Web of Science ®Google Scholar
• Heidt S, San Segundo D, Shankar S, Peripheral blood sampling for the detection of allograft rejection: biomarker identification and validation. Transplantation 2011;92(1):1-9
   PubMed Web of Science ®Google Scholar